-
EP3293186
European procedure
Extract from the Register of European Patents
EP About this file: EP3293186
| EP3293186 - PYRIMIDINONES AS FACTOR XIA INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.07.2021 Database last updated on 05.07.2024 | |
| Former | The patent has been granted Status updated on 21.08.2020 | ||
| Former | Grant of patent is intended Status updated on 15.04.2020 | ||
| Former | Examination is in progress Status updated on 01.04.2020 | ||
| Former | Grant of patent is intended Status updated on 24.11.2019 | ||
| Former | Examination is in progress Status updated on 25.01.2019 | ||
| Former | Request for examination was made Status updated on 21.09.2018 | ||
| Former | The application has been published Status updated on 09.02.2018 | Most recent event Tooltip | 30.07.2021 | No opposition filed within time limit | published on 01.09.2021 [2021/35] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543-4000 / US | [2018/11] | Inventor(s) | 01 /
DILGER, Andrew K. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 02 /
CORTE, James R. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 03 /
DE LUCCA, Indawati 9 Hunters Ridge Dr Pennington, New Jersey 08534 / US | 04 /
FANG, Tianan c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 05 /
YANG, Wu c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 06 /
WANG, Yufeng c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 07 /
PABBISETTY, Kumar Balashanmuga c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 08 /
EWING, William R. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 09 /
ZHU, Yeheng c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 10 /
WEXLER, Ruth R. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 11 /
PINTO, Donald J.P. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 12 /
ORWAT, Michael J. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | 13 /
SMITH II, Leon M. c/o Bristol-Myers Squibb Company 311 Pennington-Rocky Hill Road Pennington, New Jersey 08534 / US | [2018/11] | Representative(s) | Dehns St. Bride's House 10 Salisbury Square London EC4Y 8JD / GB | [2020/39] |
| Former [2018/11] | Kling, Edouard Swords Laboratories, Ireland Swiss Branch, Steinhausen Hinterbergstrasse 16 6312 Steinhausen / CH | Application number, filing date | 17189935.4 | 29.07.2015 | [2018/11] | Priority number, date | US201462058316P | 01.10.2014 Original published format: US 201462058316 P | [2018/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3293186 | Date: | 14.03.2018 | Language: | EN | [2018/11] | Type: | B1 Patent specification | No.: | EP3293186 | Date: | 23.09.2020 | Language: | EN | [2020/39] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 19.12.2017 | Classification | IPC: | C07D471/18, A61K31/4162, A61P7/02 | [2018/11] | CPC: |
A61P7/00 (EP,IL);
C07D471/18 (EP,IL,KR);
A61K31/4162 (KR);
A61K31/506 (KR);
A61P11/00 (EP,IL);
A61P13/12 (EP,IL);
A61P43/00 (EP,IL);
A61P7/02 (EP,IL);
A61P7/06 (EP,IL);
A61P9/00 (EP,IL);
A61P9/04 (EP,IL);
A61P9/06 (EP,IL);
A61P9/10 (EP,IL);
C07D213/61 (EP);
C07D239/34 (EP);
C07D403/10 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/43] |
| Former [2018/11] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | PYRIMIDINONE ALS FAKTOR-XIA-HEMMER | [2018/11] | English: | PYRIMIDINONES AS FACTOR XIA INHIBITORS | [2018/11] | French: | PYRIMIDINONES UTILISÉES EN TANT QU'INHIBITEURS DU FACTEUR XIA | [2018/11] | Examination procedure | 07.09.2017 | Date on which the examining division has become responsible | 14.09.2018 | Amendment by applicant (claims and/or description) | 14.09.2018 | Examination requested [2018/43] | 24.01.2019 | Despatch of a communication from the examining division (Time limit: M06) | 02.08.2019 | Reply to a communication from the examining division | 25.11.2019 | Communication of intention to grant the patent | 26.03.2020 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 16.04.2020 | Communication of intention to grant the patent | 17.08.2020 | Fee for grant paid | 17.08.2020 | Fee for publishing/printing paid | 17.08.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15747721.7 / EP3089979 | Divisional application(s) | EP20197284.1 / EP3828186 | EP23185426.6 | Opposition(s) | 24.06.2021 | No opposition filed within time limit [2021/35] | Fees paid | Renewal fee | 07.09.2017 | Renewal fee patent year 03 | 11.07.2018 | Renewal fee patent year 04 | 15.07.2019 | Renewal fee patent year 05 | 14.07.2020 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2013093484 (ONO PHARMACEUTICAL CO [JP], et al); | [A]WO2014022767 (BRISTOL MYERS SQUIBB CO [US]); | [E]WO2015116886 (BRISTOL MYERS SQUIBB CO [US]) |